Allergan Gains as Ackman Reported to Team With Valeant on Bid

Allergan Inc., the maker of the Botox wrinkle treatment, gained 12 percent in extended trading after a media report that New York hedge fund manager Bill Ackman and Valeant Pharmaceuticals International Inc. are teaming to bid on the drugmaker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.